Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06788834

Multimodal Prehabilitation in Cancer Surgery

Led by Università Vita-Salute San Raffaele · Updated on 2025-08-07

400

Participants Needed

9

Research Sites

82 weeks

Total Duration

On this page

Sponsors

U

Università Vita-Salute San Raffaele

Lead Sponsor

P

Prof. Pasquale Sansone

Collaborating Sponsor

AI-Summary

What this Trial Is About

The PROPOSE RCT is a two-arm randomized controlled trial that will be conducted to test the efficacy of a personalized, multidisciplinary pre-operative prehabilitation program (preventive prehabilitation) to reduce serious complications and facilitate recovery after surgery in high-risk patients. The multimodal prehabilitation program is a preoperative intervention that includes exercise training, nutritional therapy and anxiety reduction techniques, with the aim of preventing or mitigating the functional decline brought about by surgery. 400 patients scheduled for elective major abdominal (including urological), thoracic (including breast) or gynecological cancer surgery will be enrolled. They will be randomized (1:1 ratio) and assigned either to the intervention group (Prehabilitation) or to the control group, which will only be treated according to the usual standard of care within the Enhanced Recovery After Surgery (ERAS) pathways.

CONDITIONS

Official Title

Multimodal Prehabilitation in Cancer Surgery

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient (age > 18 years)
  • Scheduled for elective major abdominal (including urological), thoracic (including breast) or gynecological cancer surgery
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Acute or unstable cardio-respiratory conditions such as unstable angina or symptomatic severe aortic stenosis
  • Severe or end-stage organ diseases including cardiac failure NYHA classes III-IV, COPD with FEV1 <50% predicted, end-stage kidney or liver disease
  • American Society of Anesthesiologists (ASA) physical status classes 4-5
  • Disabling orthopedic and neuromuscular diseases
  • Psychosis or dementia
  • Symptomatic anemia with hemoglobin value less than 7 g/dl
  • Patients with both optimal functional capacity (Duke activity status index score > 45) and optimal nutritional status (NRS-nutrition screening tool score < 2)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Policlinico Universitario AOU Renato Dulbecco di Catanzaro

Catanzaro, Italy, Italy, 88100

Actively Recruiting

2

AOU Careggi

Florence, Italy, Italy, 50134

Not Yet Recruiting

3

Ospedale Galliera di Genova

Genova, Italy, Italy, 16128

Not Yet Recruiting

4

ASSTN GOM Niguarda

Milan, Italy, Italy, 20162

Not Yet Recruiting

5

IRCCS Ospedale San Gerardo dei Tintori

Monza, Italy, Italy, 20900

Not Yet Recruiting

6

Ospedale Vanvitelli di Napoli

Naples, Italy, Italy, 80129

Actively Recruiting

7

AOPD Padova

Padova, Italy, Italy, 35128

Not Yet Recruiting

8

Azienda sanitaria universitaria Friuli Centrale (ASU FC)

Udine, Italy, Italy, 33100

Not Yet Recruiting

9

IRCCS Ospedale San Raffaele

Milan, Milan, Italy, 20132

Actively Recruiting

Loading map...

Research Team

M

Marina LG Pieri, Medical Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here